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Background: Preventive health care is an important part of general practice however uptake of activities by
patients is variable. Monetary incentives for doctors have been used in the UK and Australia to improve rates of
screening and immunisation. Few studies have focussed on incentives for patients to attend preventive health care
examinations. Our objective was to investigate the use of a monetary incentive to increase patient attendance with
their general practitioner for a cardiovascular risk assessment (CVRA).
Methods: A pragmatic RCT was conducted in two Australian general practices. Participating GPs underwent
academic detailing for cardiovascular risk assessment. 301 patients aged 40–74, who did not have cardiovascular
disease, were independently randomised to receive a letter inviting them to a no cost cardiovascular risk
assessment with their GP, or the same letter plus an offer of a $25 shopping voucher if they attended. An audit of
patient medical records was also undertaken and a patient questionnaire administered to a sub sample of
participants. Our main outcome measure was attendance for cardiovascular risk assessment.
Results: In the RCT, 56/301(18.6%) patients attended for cardiovascular risk assessment, 29/182 (15.9%) in the
control group and 27/119 (22.7%) in the intervention group. The estimated difference of 6.8% (95% CI: -2.5% to
16.0%) was not statistically significant, P = 0.15. The audit showed that GPs may underestimate patients’ absolute
cardiovascular risk and the questionnaire that mailed invitations from GPs for a CVRA may encourage patients to
attend.
Conclusions: A small monetary incentive does not improve attendance for cardiovascular risk assessment. Further
research should be undertaken to determine if there are other incentives that may increase attendance for
preventive activities in the general practice setting.
Clinical trials registration: ACTRN12608000183381Backgroud
Most Primary Health Care (PHC) interventions to
improve the primary and secondary prevention of cardio-
vascular disease (CVD) have focussed on improvements in
identifying patients at risk [1] and multi-factorial interven-
tions, usually incorporating nurse led clinics for secondary
prevention [2]. Whilst GPs in Australia and the UK have
been offered financial incentives to reach quality improve-
ment targets, little research has explored what incentives
might encourage consumers to attend GPs for preventive* Correspondence: nigel.stocks@adelaide.edu.au
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reproduction in any medium, provided the orhealth care. Some research has examined incentives to im-
prove preventive behaviour, for instance to increase rates
of immunisation, cancer screening and smoking cessation
[3,4]. Only one general practice study conducted in
Denmark showed that attendance at preventive health
examinations for CVD was higher when the examination
was free [5]. There have been no Australian or UK studies
exploring the use of incentives to promote preventive
health examinations.
Our study aimed to trial the use of a monetary incen-
tive to increase the uptake of a cardiovascular risk
assessment (CVRA) in patients without a history of
CVD.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Stocks et al. BMC Family Practice 2012, 13:54 Page 2 of 6
http://www.biomedcentral.com/1471-2296/13/54Methods
Study type and setting
A randomised controlled trial of a monetary incentive to
improve attendance for CVRA was conducted in two Adel-
aide urban general practices (A and B). Both practices had
similar demographic and socioeconomic characteristics
(Index of socio-economic advantage-disadvantage for the
top 10 postcodes of patients in each practice 984 and 985
respectively).
Participants
Practice databases were searched to identify patients
aged 40–74 years without diagnosed CVD. GPs reviewed
the generated patient lists to exclude those that they
considered unsuitable because of serious illness, lan-
guage barriers, or recent bereavement that might affect
their participation in the study. The list was further
limited to include only one patient per household, by al-
ternately selecting a male or female patient from a
shared address.
Intervention
Letters were sent to a total of 301 patients inviting them
to attend for CVRA with their usual GP. Intervention
arm patients (n = 119) were offered a shopping voucher
(to the value of $25) for attendance within 6 months of
the invitation date. Along with the invitation, all patients
received an information sheet, consent form and a bro-
chure outlining what a CVRA entailed. Attendance slips
were also provided, to be taken to the assessment visit
to identify participants as part of the trial, and to act as
evidence of attendance. These slips were collected dur-
ing regular visits to the practices. Patients had 6 months
in which to attend for CVRA after the invitation was
sent. Reminders were not sent. All GPs were trained in
the use of a paper version of the NZ absolute cardiovas-
cular risk tables [6].
Outcome
Attendance at the general practice for a CVRA within
6 months of the invitation, as verified by collection of an
attendance slip by research staff during a 9 month follow
up period.
Randomisation
Within each practice eligible patients were randomised
to control or intervention arms using a random number
table by an independent statistician. Assignment was
weighted to the control arm (3:2) because a lower par-
ticipation rate was expected in this arm.
Sample size calculation
We assumed that 65% of patients would respond to a
letter asking them to attend for CVRA without anyincentive. To be able to detect an increase in the re-
sponse rate above 80% (a 15%+ absolute increase) in
those receiving an incentive, with 95% confidence and
80% power we calculated that we would need 150
patients from each practice (300 in total).
Audit and questionnaire
An audit of consenting participants’ medical records was
conducted between 3 and 9 months after their attend-
ance for the CV risk assessment. Details collected
included attendance date, gender, age, family history of
CVD, diabetes, smoking status, height, weight, blood
pressure, lipid analysis, current medications and relevant
referrals. The audit also recorded any CV risk calcula-
tion made at the risk assessment visit, or changes to
medications at, or since, the visit. Dates of the most
recent previous consultation, and any subsequent con-
sultations were also recorded.
A follow-up questionnaire was sent to a subgroup of
participants (practice B) to ask why they participated in
the trial (not reported here), provide an estimate of their
own CVD risk, the perceived benefit of CVRA and
whether they would have seen their GP for a CVRA
‘heart health check’ if they had not been invited.
Analysis
Descriptive statistics were used to report most data. A
binomial generalised linear model with an identity link
was used to estimate the difference in the proportions of
patients attending between the intervention and control
groups. The standard error of the estimate was not
adjusted for clustering at the practice level, as we had
only two practices and no suitable method exists to ad-
just in these circumstances. It is possible therefore that
our test may be anti-conservative.
Ethics
This study received ethics approval from the University of
Adelaide Human Research Ethics Committee. Informed
consent was obtained from all participants and patients
only entered into the trial if we received a signed consent
form by a reply paid envelop. Some patients consented to
be in the trial but did not consent to the medical record
audit.
Results
Attendance frequencies, as determined from collection
of the attendance slips, are shown in Table 1. Fifty nine
percent of all participants were female; and 57% were
aged over 60 years. A CONSORT flow chart appears in
Figure 1.
The estimated absolute difference of 6.8% (95% CI: -2.5%
to 16.0%) was not statistically significant, P=0.15 using a
binominal generalised linear model.
Table 1 Attendance for cardiovascular risk assessment
Combined
Total no Attendees/Invited 56/301 (18.6%)
Control Arm Attended/Invited 29/182 (15.9%)
Intervention Arm attended/Invited 27/119 (22.7%)
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the intervention or control group.
Characteristics of attendees
The age and gender of participants attending for CVRA
is summarised in Table 2. The data presented indicates a
similar age and gender distribution by practice and inter-
vention group, although there were slightly fewer control
group participants in the 40–49 age band and slightly
more in the 70–74 age group.Assessed for eligibility – p
aged 40 – 75   n = 11
Attended for cardiovascular risk 
assessment  n =  27/119  (22.7%) 
Did not attend for cardiovascular 
risk assessment   (n = 92)  
Intervention 
Allocated to receive letter of 
invitation and an offer of a monetary 
incentive  (n  = 119) 
Allocatio
Follow-
Total eligible patients n 
301 randomly selected 
included in the stud
Figure 1 Study flow chart.Audit
The audit of 41 (consenting) participants medical
records (out of 56 participants) enabled us to determine
the time between their most recent previous consult-
ation and their attendance for CVRA, as an indicator of
their frequency of attendance. Most of these participants
(68%) had attended the practice within 60 days prior to
their attendance for CVRA (Figure 2), suggesting that
the majority of our participants were regularly attending
patients. Confirmation of attendance dates also indicated
that 85% of participants attended within 2 months of in-
vitation and all within 6 months. Time to attendance
was similar for control and intervention groups.
Comparison of GP and audit assessed risk
Using data collected by an audit of the GP records of 41
participants we compared the GPs’ risk score recordedatients 
72 
Excluded
Pre-existing IHD, same household 
or GP reason n = 560  
Did not attend for cardiovascular 
risk assessment     (n =153) 
Control 
Allocated to receive letter of 
invitation only   (n = 182) 
Attended for cardiovascular risk 






Not required for study 
N=311 
Table 2 Characteristics of attendees for CVD risk
assessment
Practice A (I:C) Practice B (I:C) Combined (I:C)
Gender
Female 14 (6:8) 58% 19 (10:9) 59% 33 (16:17) 59%
Male 10 (6:4) 42% 13 (5:8) 41% 23 (11:12) 41%
Totals 24 100% 32 100% 56 100%
Age (years)
40–49 5 (4:1) 21% 5 (3:2) 16% 10 (7:3) 18%
50–59 7 (3:4) 29% 7 (4:3) 21% 14 (7:7) 25%
60–69 7 (4:3) 29% 9 (3:6) 27% 16 (7:9) 29%
70-74 5 (1:4) 21% 11 (5:6) 33% 16 (6:10) 29%
Totals 24 100% 32 100% 56 100%
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with one that we calculated from the available data in
the medical records. Figure 3 shows a trend toward
lower absolute CVD risk estimates by the GPs.
Questionnaire
Questionnaires were sent to 32 participants from prac-
tice B and we received 24 responses (75%) Participants
were asked to indicate their level of risk (from extremely
low risk to extremely high risk) by marking a cross on a
visual analogue scale. Their responses were compared,
for intervention (I) and control (C) groups and sum-
marised in Table 3 below. They were also asked if they
would have had the CVD check up for their ‘heart
health’ if they had not received an invitation to visit their
GP, 12 of 23 respondents said no.
Discussion
Main results
The results of our RCT showed that attendance after a
mailed invitation to patients aged 40–75 for CVRA was
low (15.9%) and that a $25 monetary incentive did not
lead to a statistically significantly increase in attendance,
although there was an absolute difference in attendance
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Figure 2 Participants’ recent attendance frequency.GPs in this study tended to underestimate their patients
CVD risk based on available information in the medical
records, that participants in the intervention and control
groups had similar perceptions of their future CVD risk
and that almost half the participants from one practice
would not have had a CVRA without the prompt pro-
vided by the invitation letter.
Our desired behaviour was attendance for CVRA,
which has been promoted recently [7]. Although the
cost-effectiveness of CVRA is yet to be determined
CVRA can facilitate the management of individual
patients [8]. We could have chosen the 45–49 year old
health check, a separate item number in the Australian
fee for service system ($104.00 AUS), or any other pre-
ventive health activity, but the CVRA was applicable to
everyone in the selected age range, except those with
established CVD. We were interested in a proof of
principle and although responses may vary between
desired activities the addition of an appropriate incentive
might be expected to improve response rates.
We can only speculate why the uptake for CVRA
was low and why a small monetary incentive did not
significantly improve attendance rates. In Australia up
to 85% of patients visit their GP at least once during
a calendar year with most Australians visiting 2-3
times per year [9,10]. This means there are potentially
many opportunities for GPs to assess cardiovascular
risk factors and calculate a cardiovascular risk score.
It is possible that the patients we approached had
already undertaken a CVRA or at least had their BP,
fasting glucose and cholesterol measured. Patients
would therefore have little motivation for a repeat as-
sessment. However we know that patients receive
only about 60% of indicated preventive services that
are indicated for them [11-14] and a recent study in
Australia has shown that there are gaps in recording
and managing BP and lipids in Australian general
practice [15]. There is also evidence that patients who
are at high risk of a cardiovascular event are under-
treated [16]. Another explanation may in involve
patients’ perception of their risk for cardiovascular
disease. In a study from the Netherlands many
patients were deemed to be at low risk and there was
a mismatch between perceived and actual risk with 4
in 5 high risk patients believing incorrectly that were
at low risk and 1 in 5 low risk patients believing they
were at high risk [17]. This could reduce the number
of patients believing that CVRA would be beneficial
to them and hence affect attendance rates.
We found that GPs in this study tended to underesti-
mate the CVD risk of their patients. This could be
explained if GPs failed to incorporate modifying factors
such family history of premature heart disease, impaired
glucose tolerance or BMI> 30 patients' absolute risk.





























Figure 3 Comparison of GP and audit estimates of participants' absolute CVD risk score.
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tions of CVD risk [18-20]. This may have consequences
for the preventive care offered and potentially health
outcomes so we should consider better training and/or
the use of electronic calculators to improve CVD risk es-
timation. Our questionnaire also highlighted that invit-
ing patients for CVRA may be worthwhile with almost
half indicating that the invitation alone encouraged them
to attend and have their ‘heart health’ assessed.
Limitations
This study had several limitations. The absolute
number of patients responding in the RCT was small
although the observed difference in attendance was
almost 7%. Non-attendees may have already had
their cardiovascular risk assessed, or may have been
concerned that it was a research study. Response
rates to a letter(s) or telephone reminder for pre-
ventive health care in general practice can vary con-
siderably; for women who had not had a cervical
smear in the past 3 years only 10.7% responded to a
letter over 6 months vs 6.3% in the control [9]
whereas for a group of preventive activities the gen-
eral procedure completion rate was 42% in a studyTable 3 Participants rating of their own CVD risk in the
next 5 years
Intervention% Control%
% 5 year CVD risk on visual analogue
scale
0-24% 7 27% 5 18%
25-49% 10 38% 17 61%
50-74% 8 31% 5 18%
75-100% 1 4% 1 4%
Total 26 100%28 100%
The X2 test for trend (df3) was 2.77 p = 0.428.from Ottawa. [10] Resource limitations limited our
RCT to two practices and prevented sending remin-
ders which have been shown to increase response
rates [21]. Invitation letters have been shown to be
better than opportunistic health checks in general
practice [22] although a Canadian study demon-
strated that a telephone invitation to a health aware-
ness program may be better than a letter, but the
response to a letter at 44% was still substantial [23].
The findings from our questionnaire confirm these
previous studies.
Finally we could not conduct a double blinded trial be-
cause of the obvious difficulties, participants had to be
informed about the study and those in incentive arm
had to know they would receive a payment if they
attended. We did not inform GPs which participants
were in the incentive arm, but we could not stop
patients discussing this with their doctor. Attendance
slips were collected by research staff who did not know
which group a patient was in and initial analysis was
blinded.
Conclusions
We believe that this is the first study of its kind in
Australia and provides evidence that the use of a
small monetary incentive to promote a preventive ac-
tivity does not work. It is likely that incentives for
medication adherence for diagnosed conditions -
where the benefits of treatment may be more imme-
diately evident and the debate about payments more
topical [24,25] - differ from the offer of an incentive
for preventive care, where individual benefits are less
clear but gains for the community potentially large.
Despite this negative result further research with
patients is required to determine what, if any, incen-
tives may encourage attendance for preventive activ-
ities in primary care.
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